Validation of single-time-point dosimetry for [ 177 Lu] Lu-PSMA-617 therapy using population-based Time Dose Factors (EANM 2026) - Sep 29, 2026 - Abstract #EP-1013; "Population-based time-integration coefficients applied on a single SPECT/CT acquisition at day-4 post injection provided the most robust compromise, except for kidneys, and overall yielded better results than Hänscheid and Jackson methods."
Clinical • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Prostate Cancer • Solid Tumor
|
|
A. Terro 1; T. Zaragori 2, 3; C. Boursier 4; P. Vera 1, 5; P. Decazes 1, 5; L. Imbert 3, 4; A. Dieudonné 1, 5
|